Form 4 for CHRS Coherus Oncology, Inc.
Accepted 2023-11-24 00:00:00 ET · period of report 2023-11-22 · accession 0001610717-23-000363 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-11-24 | 2023-11-22 | CHRS | Lanfear Dennis M | Pres, CEO, Dir | M - OptEx | $1.42 | +299.9K | 954.8K | +46% | +$425.9K |
| D | 2023-11-24 | 2023-11-22 | CHRS | Lanfear Dennis M | Pres, CEO, Dir | S - Sale+OE | $2.02 | -223.1K | 731.7K | -23% | -$450.7K |
| D | 2023-11-24 | 2023-11-22 | CHRS | Lanfear Dennis M | Pres, CEO, Dir | M - OptEx | $0.00 | -299.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-22 | M | A | 41,000 | $1.42 | 695,853 | D | — | — | |
| 2 | Common | Common Stock | 2023-11-22 | S | D | 223,100 | $2.02 | 731,693 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $2.000 to $2.055. The price reported above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2023-11-22 | M | A | 258,940 | $1.42 | 954,793 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2023-11-22 | M | D | 299,940 | $0.00 | 0 | D | $1.42 · — to 2023-11-22 | 299,940 Common Stock | (F6) The underlying shares subject to the option vested and became exercisable in successive, equal monthly installments over four years measured from July 20, 2013. |